Barclays Maintains an 'Equalweight' on Medicis (MRX); Is Another Bidder Out There?
Tweet Send to a Friend
Barclays maintains an 'Equalweight' on Medicis (NYSE: MRX) price target of $44.00 (from $35.00).
Analyst, Douglas D. Tsao, said ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Analyst, Douglas D. Tsao, said ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
